克西拉不会在老鼠中增强芬太尼尔强化:一种行为经济分析
Celsey M St Onge1, Jeremy R Canfield2, Allison Ortiz3
1Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA; Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Drug and alcohol dependence
|April 9, 2024
概括
克西拉不会增加芬太尼.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
背景情况:
- 非法造芬太尼与西拉是一种新兴的公共卫生威胁.
- 这种组合的临床理由尚不清楚,需要进行临床前研究.
- 了解芬太尼-西拉相互作用对于公共卫生战略至关重要.
研究的目的:
- 为了研究芬太尼和西拉之间的药理动力学和药理动力学相互作用.
- 为了确定西拉是否增强了芬太尼的强化或成作用.
- 为了探索芬太尼-克西拉联合使用的行为经济后果.
主要方法:
- 在雄性和雌性大鼠中进行药物自我给药测定.
- 行为经济分析,包括固定比率和渐进比率计划.
- 芬太尼和西拉的血度的药理动力学评估.
主要成果:
- 芬太尼,但不是克西拉,在自我管理任务中充当了增强剂.
- 克西拉没有显著改变芬太尼尔强化剂或自我给药.
- 同时服用芬太尼和西拉并没有改变药理动力学特征.
结论:
- 克西拉似乎没有增强芬太尼的成潜力.
- 观察到非法芬太尼与西拉的改缺乏明确的药理学依据.
- 需要进一步的研究,以了解芬太尼-西拉改造背后的原因.
更多相关视频
07:50A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
Published on: January 29, 2017
9.6K
10:35A Procedure to Study the Effect of Prolonged Food Restriction on Heroin Seeking in Abstinent Rats
Published on: November 11, 2013
11.1K
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
287
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
287
Parenteral Anesthetics: Overview
119
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
119
